Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Warren Olanow

Showing results (141-150 of 144) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 144 results.
The Lancet. Neurology|December 15, 2023
Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trialAndrew McGarry, Shane Rosanbalm, Mika Leinonen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 17, 2004
Levodopa in the treatment of Parkinson's disease: current controversiesC Warren Olanow, Yves Agid, Yoshi Mizuno, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 27, 2018
Movement disorder society criteria for clinically established early Parkinson's diseaseDaniela Berg, Charles H Adler, Bastiaan R Bloem, et al.
Neurology|February 28, 2020
Disease modification and biomarker development in Parkinson disease: Revision or reconstruction?Alberto J Espay, Lorraine V Kalia, Ziv Gan-Or, et al.
Pageof 15

Showing results (141-150 of 144) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 144 results.
The Lancet. Neurology|December 15, 2023
Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trialAndrew McGarry, Shane Rosanbalm, Mika Leinonen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 17, 2004
Levodopa in the treatment of Parkinson's disease: current controversiesC Warren Olanow, Yves Agid, Yoshi Mizuno, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 27, 2018
Movement disorder society criteria for clinically established early Parkinson's diseaseDaniela Berg, Charles H Adler, Bastiaan R Bloem, et al.
Neurology|February 28, 2020
Disease modification and biomarker development in Parkinson disease: Revision or reconstruction?Alberto J Espay, Lorraine V Kalia, Ziv Gan-Or, et al.
Pageof 15